Jupiter Medical Center Opens New Clinical Trial on Biomarker Analysis for Chronic Lymphocytic Leukemia Patients


JUPITER, Fla. (February 18, 2014) – Jupiter Medical Center’s Clinical Research Department opened a new clinical trial, sponsored by OPKO Health, for collection of human bio-specimens for biomarker analysis from patients with Chronic Lymphocytic Leukemia (CLL). The collection involves identification and validation of certain receptors from blood and/or bone marrow from patients with CLL. OPKO Health has developed technology that detects specific antibodies of cancers and other diseases. Through this clinical trial, the development of accurate and reliable blood tests to diagnose cancers could have a profound effect on disease outcome.

To be eligible to participate, patients must be at least 18 years of age, undergoing no cancer treatment at time of enrollment, diagnosed with CLL and have a lymphocyte count greater than 5,000. Patients must not have been treated or diagnosed for an additional type of cancer within the past year. If eligible, there will be one blood draw. A bone marrow aspirate, if available through usual medical evaluation, may also be collected.

Jupiter Medical Center’s Clinical Research Department will screen patients, obtain consent for participation, and then provide OPKO Health with qualifying blood specimens and/or bone marrow aspirate for the clinical trial.

For more information about this clinical trial, please contact Jeanine Secor, RN, BSN, CCRP, Jupiter Medical Center Clinical Research Director, at (561) 263-5791.

The Ella Milbank Foshay Cancer Center at Jupiter Medical Center is accredited by the Commission on Cancer. As part of the standards for accreditation, Jupiter Medical Center began offering clinical research trials in 2001. To date, there have been more than 200 clinical trials with sixteen open trials currently available. Clinical research trials are an additional facet to Jupiter Medical Center’s comprehensive approach to treatment and world-class care of its patients. This venture is another opportunity for Jupiter Medical Center to continue to support bioscience and research in the community.

About Jupiter Medical Center
A not-for-profit 283-bed regional medical center consisting of 163 private acute care hospital beds and 120 long-term care, sub-acute rehabilitation and Hospice beds, Jupiter Medical Center provides a broad range of services with specialty concentrations in oncology, imaging, orthopedics & spine, digestive health, emergency services, lung & thoracic, women’s health, weight management and men’s health. Founded in 1979, the Medical Center has approximately 1,500 team members, 575 physicians and 640 volunteers. For more information on Jupiter Medical Center, please call (561) 263-2234 or visit www.jupitermed.com.

New Clinical Trial_Biomarker Analysis